Growth hormone (GH), insulin-like growth factors (IGFs), and IGF-binding protein-3 (IGFBP-3) in a child with Proteus syndrome

✍ Scribed by Rudolph, Günter ;Blum, Werner F. ;Jenne, Enno W. ;Schöning, Martin ;Enders, Herbert ;Meitinger, Thomas ;Murken, Jan D. ;Kampik, Anselm

• Publisher: John Wiley and Sons
• Year: 1994
• Tongue: English
• Weight: 685 KB
• Volume: 50
• Category: Article
• ISSN: 0148-7299
• DOI: 10.1002/ajmg.1320500213

✦ Synopsis

Proteus syndrome is a congenital hamartomatous disorder characterized by partial overgrowth involving all germ layers. A somatic mutation model has been proposed since familial cases are extremely rare. We report on a 3-year-old girl with typical manifestations of Proteus syndrome, including local, asymmetric hypertrophy of various parts of the body. Total body length was reduced. Serum levels of IGF-I and especially IGF-I1 and their major growth hormone dependent binding protein (IGFBP-3) were significantly reduced, although growth hormone secretion after a pharmacological stimulus was normal.

In vitro studies of fibroblasts derived from hypertrophied tissue showed normal IGF-I production and somewhat reduced IGF-I1 and IGFBP-3 production as compared to normal human skin fibroblasts.

Affinity cross-linking experiments showed that fibroblasts of the affect tissue in Prokus syndrome produced an unusual pattern of IGF bindings proteins containing large amounts of an IGFBP with high affinity to IGF-11. The data suggest that IGF production is generally disturbed in Proteus syndrome with imbalanced levels of specific IGFBP in affected tissue. D 1994 Wiley-Liss, Inc.